5th Workshop on the Characterization of Heparin Products

This workshop encouraged open discussion and debate on the physico-chemical and functional characterization of therapeutic products derived from heparin and the exploration of possible clinical and regulatory implications as seen from different viewpoints. Symposium was organized by the National Institute for Biological Standards and Control, the European Directorate for the Quality of Medicines and Healthcare (Council of Europe), and The United States Pharmacopeial Convention.

Topics:

• Unfractionated Heparin (UFH): Characterization and Standardization
• UFH Active Pharmaceutical Ingredient (API) Sourcing and Production
• UFH Pharmacopeial Monograph Revision Updates
• Implementation of New and Revised Monograph Methods—Lessons Learned and Practical Hints
• Low Molecular Weight Heparins (LMWH)
• New Pharmacopeial Methods, Manufacturing Process Controls, and Characterizations
• All Heparin Products  
• Regulatory and Dossier Requirements